Document:

kop-ex10114_657.htm

AMENDMENT NO. 2 TO EMPLOYMENT LETTER AGREEMENT

 

THIS AMENDMENT NO. 2 TO EMPLOYMENT LETTER AGREEMENT (“Amendment”) is made and entered into as of May 5, 2017 by and among Koppers Performance Chemicals Inc. (f/k/a Osmose, Inc.) (the “Company”) and Stephen C. Reeder (“Employee”).

 

The Company and Employee are parties to an Employment Letter Agreement, dated as of March 14, 2012 (the “Original Agreement”), as amended by that certain Amendment to Employment Letter Agreement, dated as of June 25, 2014 (the “First Amendment” and, together with the Original Agreement, the “Employment Agreement”).

 

Effective on and as of the date hereof, the parties have agreed to amend the Employment Agreement on the terms and subject to the conditions set forth below.

 

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:

 

	
1.
	
The Employment Agreement will be amended by:

 

	
 
	
a.
	
Deleting subsection (E) in the paragraph entitled “Termination” on page three of the Original Agreement in its entirety.

 

	
 
	
b.
	
Deleting the phrase “(the foregoing subsections (B), (C), (D) and (E) collectively referred to herein as the “Severance Payments”)” in lines 21 and 22 in the paragraph entitled “Termination” on page three of the Original Agreement and replacing it with the phrase “(the foregoing subsections (B), (C) and (D) collectively referred to herein as the “Severance Payments”)”.

 

	
 
	
c.
	
Deleting Section 2(h) of the First Amendment in its entirety and replacing it with “RESERVED.”

 

	
2.
	
Except as expressly amended by this Amendment, the Employment Agreement, and all of the terms and conditions thereof, will remain in full force and effect.

 

	
3.
	
Each party agrees, on written request of the other party, to do all acts and execute, deliver and perform all additional documents, instruments and agreements that may be reasonably required by the requesting party to implement the provisions and purposes of this Amendment.

 

	
4.
	
This Amendment may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Amendment, but all of which together will constitute one and the same Amendment.

 

[Signatures appear on following page]

 

IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.  

 

 

KOPPERS PERFORMANCE CHEMICALS INC.

 

By _/s/ Steven R. Lacy__________

Name:  Steven R. Lacy

Title: Secretary

 

 

 

EMPLOYEE

 

_/s/ Stephen C. Reeder ______________

Stephen C. ReederEXHIBIT 10.7 

SUBSCRIPTION AGREEMENT

 

Oxygen Therapy, Inc.

233 Needham Street

Suite 300

Newton, MA 02464

Tel. (617) 454-1199

 

THIS SUBSCRIPTION AGREEMENT
made this _____day of ______________, 2017 by and between Oxygen Therapy, Inc., a Delaware corporation (hereinafter “ Company”),
and the undersigned Subscriber (hereinafter “Subscriber”), who, for and in consideration of the mutual promises and
covenants set forth herein, do hereto agree as follows:

 

1. Subscription. The Subscriber hereby
subscribes for ____________ Shares (hereinafter “Shares”) of the Company’s Common Stock, at a price of $1.00
per Share, and herewith tenders to the Company by certified bank funds for the subscription in the amount of US$________________,
which the Subscriber tenders herewith as payment for the Shares. 

 

This offering will terminate 180 days from
the effective date of the Prospectus (as such term is defined below), although we may close the offering on any date prior if the
offering is fully subscribed. As there is no minimum amount of proceeds to be raised, the funds will be deposited in the Company’s
operating account and used set forth in the Use of Proceeds section of this prospectus. If the Company does not sell all 19,081,038
Shares within 180 days from the date of the Prospectus, the offering for the balance of the Shares will terminate and we will sell
no further shares pursuant to the offering.

 

This Subscription Agreement (hereinafter “Subscription”)
is an offer by the Subscriber to subscribe for the securities offered by the Company, and, subject to the terms hereof, shall become
a contract for the sale of said securities upon acceptance thereof by the Company.

 

2. Acknowledgement. The
undersigned acknowledges that, prior to signing this Subscription Agreement and making this offer to purchase, he or she has received
the Prospectus describing the offering of the Shares by the Company as filed with the United States Securities and Exchange Commission
(the “Prospectus”), and that he or she understands the risks of and other considerations relevant to, a purchase of
the Shares, including those described under the caption “Risk Factors” in the Prospectus. The undersigned understands
that the resale of the Shares must be effected in reliance on exemptions from qualification in certain states. The undersigned
represents that the undersigned is a resident of the state set forth in the “Subscriber Information” section of the
signature page below. The undersigned further acknowledges that, if the undersigned is a natural person, the undersigned is at
least 21 years of age.

 

3. Acceptance of Subscription
and Delivery of Shares. This Subscription Agreement is made subject to the Company’s discretionary right to accept or
reject the Subscription herein. If the Company for any reason rejects this Subscription, the Subscription will be refunded in full,
without interest, and this Subscription Agreement shall be null, void and of no effect. Acceptance of this Subscription by the
Company will be evidenced by the execution hereof by an officer of the Company. Delivery of the Shares subscribed for herein will
be made within three (3) days following the acceptance of this Subscription by the Company.

 

    	 

    	 	 

    

 

The undersigned hereby executes this Subscription
Agreement as of the ____ day of __________, 2017, at ________________________, _______________________

 

                                      (city)                                           (state
or country)

 

	Investor Signature (if individual)	 	 
	 	 	 
	Print Name:	 	 

 

If more than one name on the stock certificate,
sign below:

 

	Second Investor Signature	 	 
	 	 	 
	Print Name:	 	 
	 	 	 
	Address, if different from First Investor	 	 
	 	 	 
	 	 	 

 

If more than one name on the stock certificate,
check status below:

 

	_____	Tenants in Common
	 	 
	_____	Joint Tenants with Right of Survivorship
	 	 
	_____	Other (describe): ______________________________________

 

Investor                         (if
entity)

 

	Print Entity Name:	 	 
	 	 	 
	Print Signatory Name:	 	 
	 	 	 
	By (signature):	 	 
	 	 	 
	Title:	 	 

 

Please complete the Subscriber information
on the following page.

 

    	2

    	 	 

    

 

Subscriber Information:

 

	Name:	 	 
	Address:	 	 
	 	 	 

 

State or Country: _______________________________Postal
Code:________

 

Taxpayer ID Number (if U.S. subscriber):____________________

 

	Driver’s License / Passport	 	 	 
	 	 	 	 
	Identification Number	 	 	 

 

    	3snss-ex102_559.htm

Exhibit 10.2

SUNESIS PHARMACEUTICALS, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

Non-employee members of the board of directors (the “Board”) of Sunesis Pharmaceuticals, Inc. (the “Company”) shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Policy (this “Policy”). The cash and equity compensation described in this Policy shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”) who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Policy shall remain in effect until it is revised or rescinded by further action of the Board. The terms and conditions of this Policy shall supersede any prior cash or equity compensation arrangements between the Company and its Non-Employee Directors.

1. Cash Compensation.

(a) Annual Retainers. Each Non-Employee Director shall be eligible to receive an annual retainer of $40,000 for service on the Board. In addition, a Non-Employee Director shall receive the following additional annual retainers, as applicable:

(i) Chairperson of the Board. A Non-Employee Director serving as Chairperson of the Board shall receive an additional annual retainer of $20,000 for such service.

(ii) Chairperson of the Audit Committee. A Non-Employee Director serving as Chairperson of the Audit Committee shall receive an additional annual retainer of $20,000 for such service.

(iii) Member of the Audit Committee. A Non-Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive an additional annual retainer of $10,000 for such service.

(iv) Chairperson of the Compensation Committee. A Non-Employee Director serving as Chairperson of the Compensation Committee shall receive an additional annual retainer of $15,000 for such service.

(v) Member of the Compensation Committee. A Non-Employee Director serving as a member of the Compensation Committee (other than the Chairperson) shall receive an additional annual retainer of $7,500 for such service.

(vi) Chairperson of the Nominating and Corporate Governance Committee. A Non-Employee Director serving as Chairperson of the Nominating and Corporate Governance Committee shall receive an additional annual retainer of $7,500 for such service.

(vii) Member of the Nominating and Corporate Governance Committee. A Non-Employee Director serving as a member of the Nominating and Corporate Governance Committee (other than the Chairperson) shall receive an additional annual retainer of $5,000 for such service.

(b) Payment of Retainers. The annual retainers described in Section 1(a) shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company on or about the 15th day of the third month of the quarter in which such retainer is earned.  The Non-Employee Director shall be deemed to have earned the retainer for a quarter if the Non-Employee Director serves for any portion of such quarter.

2. Equity Compensation. Non-Employee Directors shall be granted the equity awards described below. The awards described below shall be granted under and shall be subject to the terms and provisions of the 2011 Equity Incentive Plan (the “2011 Plan”) and shall be granted subject to the execution and delivery of award agreements, including attached exhibits, in substantially the same forms previously approved by the Board, setting forth the vesting schedule applicable to such awards and such other terms as may be required by the Equity Plan.

(a) Initial Grants. A person who is initially elected or appointed to the Board, and who is a Non-Employee Director at the time of such initial election or appointment, shall be eligible to receive on the last day of the month in which such initial election or appointment occurs a stock option to purchase 37,500 shares of the Company’s common stock. The awards described in this Section 2(a) shall be referred to as “Initial Grants.” No Non-Employee Director shall be granted more than one Initial Grant.

 

(b) Annual Grants. A person who is a Non-Employee Director immediately following each annual meeting of the Company’s stockholders who will continue to serve as a Non-Employee Director immediately following such annual meeting shall be automatically granted on the last day of the month in which such annual meeting occurs an option to purchase 25,000 shares of the Company’s common stock. The awards described in this Section 2(b) shall be referred to as “Annual Grants.” For the avoidance of doubt, a Non-Employee Director elected for the first time to the Board at an annual meeting of the Company’s stockholders shall only receive an Initial Grant in connection with such election, and shall not receive any Annual Grant on the date of such meeting as well.  Additionally, (i) a Non-Employee Director elected or appointed to the Board for the first time within 3 months prior to the date of the annual meeting of the Company’s stockholders, shall not receive an Annual Grant in connection with such annual meeting of the Company’s stockholders and (ii) a Non-Employee Director elected or appointed to the Board for the first time more than 3 months prior to the date of the annual meeting of the Company’s stockholders but after the date of the prior year’s annual meeting of the Company’s stockholder, shall receive pro-rata Annual Grant based on the number of calendar quarters in which the Non-Employee Director has served prior to the date of the annual meeting of the Company’s stockholders.    

(c) Termination of Employment of Employee Directors. Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their employment with the Company and any parent or subsidiary of the Company and remain on the Board will not receive an Initial Grant pursuant to Section 2(a) above, but to the extent that they are otherwise eligible, will be eligible to receive, after termination from employment with the Company and any parent or subsidiary of the Company, Annual Grants as described in Section 2(b) above.

(d) Terms of Awards Granted to Non-Employee Directors.

(i) Purchase Price. The per share exercise price of each option granted to a Non-Employee Director shall equal 100% of the Fair Market Value (as defined in the 2011 Plan) of a share of common stock on the date the option is granted.

(ii) Vesting. Each Initial Grant shall vest and become exercisable in 24 equal monthly installments over the two year period following the date of grant, subject to the Non-Employee Director continuing in service on the Board through each such vesting date. Each Annual Grant shall vest and/or become exercisable in 12 equal monthly installments over the one year period following the date of grant, subject to the Non-Employee Director continuing in service on the Board through each such vesting date. 

(iii) Term. The term of each stock option granted to a Non-Employee Director shall be ten years from the date the option is granted.

3. Expenses. Non-Employee Directors shall be reimbursed for all reasonable out-of-pocket expenses incurred in attending Board and committee meetings.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]